Delivery Order SPE2DB25D9348-SPE2DB25FNMNN

Award Date 11/15/24
Potential Completion Date 12/9/24
Potential Value $80K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $120,428.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) valued up to $499,999,999 that the DLA has with DMS Pharmaceutical Group to provide a wide range of pharmaceutical products and medical supplies to military health facilities worldwide. This delivery order is for the...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $80,218.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vials and has an ultimate completion date of January 2, 2025. DMS Pharmaceutical Group Inc. is the prime contractor and there is no set-aside designation for this award. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $96,342.84 contract is to provide 4566606893 - KEYTRUDA 100 MG/4 ML VIAL 4ML, a specialty oncology medication, to support the medical supply needs of military healthcare facilities. This delivery order is part of DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $48,171.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vial (4 ml) and does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,094.78 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 100 mg/4 ml vials of KEYTRUDA, a prescription drug, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group has a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $48,131.04, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vials by May 9, 2024. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
The Defense Logistics Agency (DLA) awarded a $59,528.32 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for Keytruda 100 mg/4 ml vials and has an ultimate completion date of April 26, 2022. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $80,218.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vials, a specialized oncology medication, with a period of performance through September 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $32,087.36, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Keytruda, a cancer immunotherapy drug, with a completion date of May 28, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $48,131.04 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vial, a prescription cancer drug, with a period of performance through April 2024. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract SPE2DB24FYN74 with DLA, valued at up to $4,999,999, which...
  • SPE2DB25D9348
    Indefinite Delivery Contract
  • SPE2DB25D9348-SPE2DB25FNMNN
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $80,285.70 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4566490089 KEYTRUDA 100 MG/4 ML VIAL 4ML, a prescription oncology medication, with a completion date of December 9, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military healthcare facilities and veterans' medical centers nationwide. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows for the issuance of firm fixed-price delivery orders for a wide variety of pharmaceutical products. There is no set-aside designation associated with this specific delivery order.

Generated 2/14/25, 9:36 AM